These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 4027870

  • 1. Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.
    Haid M, Khandekar JD, Christ M, Johnson CM, Miller SJ, Locker GY, Merrill JM, Reisel H, Hatfield A, Lanzotti V.
    Cancer; 1985 Sep 15; 56(6):1311-5. PubMed ID: 4027870
    [Abstract] [Full Text] [Related]

  • 2. Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report.
    Tapazoglou E, Kish J, Ensley J, Al-Sarraf M.
    Am J Clin Oncol; 1988 Aug 15; 11(4):474-8. PubMed ID: 3407628
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors.
    Eagan RT, Dinapoli RP, Cascino TL, Scheithauer B, O'Neill BP, O'Fallon JR.
    J Neurooncol; 1987 Aug 15; 5(4):309-14. PubMed ID: 3440875
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I trial of 5-day continuous infusion aziridinylbenzoquinone (AZQ, diazaquone, NSC 182968).
    Sigman LM, Van Echo DA, Whitacre MY, Aisner J, Budman DA, Shulman P.
    Am J Clin Oncol; 1986 Feb 15; 9(1):79-82. PubMed ID: 3953494
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).
    Carey RW, Comis RL, Anbar D, Kennedy BJ, Capizzi RL, Shulman P, Booth BW, Green M, Raich PC.
    Cancer Treat Rep; 1983 Jan 15; 67(1):95-6. PubMed ID: 6616498
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of patients with recurrent primary brain tumors with AZQ.
    Schold SC, Friedman HS, Bjornsson TD, Falletta JM.
    Neurology; 1984 May 15; 34(5):615-9. PubMed ID: 6538653
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT, Hancock CH, Mondora A, Hoffman NW.
    Cancer Res; 1984 Feb 15; 44(2):831-5. PubMed ID: 6692381
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.